Angiogenic Polypeptides in Breast Cancer: Expression of Mrna’s in Primary Human Tumours, MCF-7 Cell Transfection and Xenograft Models

[1]  S. Donnini,et al.  An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. , 1997, Cancer research.

[2]  S. Fox,et al.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes , 1997, Cancer research.

[3]  A. Harris,et al.  The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. , 1997, Cancer research.

[4]  S. Akiba,et al.  Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. , 1996, Journal of the National Cancer Institute.

[5]  L. Ellis,et al.  Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. , 1996, Journal of the National Cancer Institute.

[6]  J. Folkman.  What is the role of thymidine phosphorylase in tumor angiogenesis. , 1996, Journal of the National Cancer Institute.

[7]  A. Harris,et al.  The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. , 1996, Cancer research.

[8]  S. Fox,et al.  The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. , 1996, British Journal of Cancer.

[9]  A. Harris,et al.  The increased expression of adhesion molecules ICAM‐3, E‐ and P‐selectins on breast cancer endothelium , 1995, The Journal of pathology.

[10]  S. Fox,et al.  Thymidine phosphorylase is angiogenic and promotes tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Harris,et al.  Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. , 1995, Journal of the National Cancer Institute.

[12]  T. Bourne,et al.  Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. , 1994, Journal of the National Cancer Institute.

[13]  T. Furukawa,et al.  Angiogenic activity of enzymes , 1994, Nature.

[14]  E. Manseau,et al.  Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. , 1993, The American journal of pathology.

[15]  N. Dodsworth,et al.  Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. , 1993, European journal of biochemistry.

[16]  R. Bicknell,et al.  Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. , 1992, Biochemistry.

[17]  K. Miyazono,et al.  Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. , 1992, Biochemical and biophysical research communications.

[18]  K. Miyazono,et al.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor , 1989, Nature.